ES2145379T3 - Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral. - Google Patents

Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral.

Info

Publication number
ES2145379T3
ES2145379T3 ES96300727T ES96300727T ES2145379T3 ES 2145379 T3 ES2145379 T3 ES 2145379T3 ES 96300727 T ES96300727 T ES 96300727T ES 96300727 T ES96300727 T ES 96300727T ES 2145379 T3 ES2145379 T3 ES 2145379T3
Authority
ES
Spain
Prior art keywords
sup
dioxabiciclo
apoplejia
octanes
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96300727T
Other languages
English (en)
Inventor
Kengo Akimoto
Shiro Morimoto
Yasuo Matsumura
Hajime Yoshizumi
Tetsuo Murakami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2145379T3 publication Critical patent/ES2145379T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA PRESENTE INVENCION EXPONE UN PREVENTIVO O MEJORANTE DE LA HIPERTENSION O DE LOS SINTOMAS MEDICOS CAUSADOS POR LA MISMA Y UNA COMIDA O BEBIDA QUE PREVIENE O MEJORA LA HIPERTENSION O SINTOMAS MEDICOS CAUSADOS POR LA MISMA QUE CONTIENE PARA SU INGREDIENTE ACTIVO UN DERIVADO DE DIOXABICICLO[3.3.0]OCTANO REPRESENTADO POR LA FORMULA (2) DONDE R{SUP,1}, R{SUP,2}, R{SUP,3}, R{SUP,4}, R{SUP,5}, Y R{SUP,6} SON RESPECTIVA E INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO QUE TIENE DE 1 A 3 ATOMOS DE CARBONO, O R{SUP,1} Y R{SUP,2} Y/O R{SUP,4} Y R{SUP,5} CONJUNTAMENTE REPRESENTAN UN GRUPO METILENO O UN GRUPO ETILENO, Y N, M Y L REPRESENTAN 0 O 1.
ES96300727T 1995-02-01 1996-02-01 Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral. Expired - Lifetime ES2145379T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1527695 1995-02-01
JP7070205A JPH08268887A (ja) 1995-02-01 1995-03-28 高血圧症又はそれに起因する医学的症状の予防又は改善剤

Publications (1)

Publication Number Publication Date
ES2145379T3 true ES2145379T3 (es) 2000-07-01

Family

ID=26351395

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96300727T Expired - Lifetime ES2145379T3 (es) 1995-02-01 1996-02-01 Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral.

Country Status (11)

Country Link
US (1) US5889046A (es)
EP (1) EP0729753B1 (es)
JP (1) JPH08268887A (es)
KR (2) KR100399671B1 (es)
AT (1) ATE192648T1 (es)
AU (1) AU705308B2 (es)
CA (1) CA2168513A1 (es)
DE (1) DE69608155T2 (es)
DK (1) DK0729753T3 (es)
ES (1) ES2145379T3 (es)
PT (1) PT729753E (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180001A (ja) * 1997-09-08 1999-03-23 Toshihiko Osawa 高脂血症予防剤
US6737087B2 (en) 2001-03-13 2004-05-18 Sung-jin Kim Composition containing Asiasari Radix extracts for protecting brain cells and improving memory
US7357951B2 (en) * 2002-04-12 2008-04-15 Ajinomoto Co., Inc. Composition for preventing atherosclerosis
WO2004105749A1 (ja) * 2003-05-27 2004-12-09 Suntory Limited 自律神経調節作用を有する組成物およびその使用方法
TW200536525A (en) * 2004-03-31 2005-11-16 Suntory Ltd Adiponectin enhancer
WO2006016682A1 (ja) * 2004-08-09 2006-02-16 Suntory Limited 血管弾力性改善剤およびその使用
AU2005320579B2 (en) * 2004-12-28 2011-09-22 Suntory Holdings Limited Sesamin/episesamin compositions
WO2006106986A1 (ja) * 2005-03-31 2006-10-12 Fuji Chemical Industry Co., Ltd. 血管不全改善剤
TWI406867B (zh) 2005-09-30 2013-09-01 Suntory Holdings Ltd And a method for producing a high content of episesamin
WO2007114013A1 (ja) 2006-03-31 2007-10-11 Suntory Limited リグナン類化合物含有組成物
JP5409989B2 (ja) * 2006-04-03 2014-02-05 サントリーホールディングス株式会社 セサミン類含有動物用飲食物
EP2319537B1 (en) 2008-06-18 2015-04-29 Shiseido Company, Ltd. Stabilizer for lymph vessel
KR101124621B1 (ko) 2009-12-02 2012-03-19 한국생명공학연구원 세사민을 유효성분으로 함유하는 혈관신생 촉진제
KR20130046115A (ko) 2011-10-27 2013-05-07 (주)아모레퍼시픽 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
KR102016078B1 (ko) * 2012-11-30 2019-08-30 (주)아모레퍼시픽 심장 질환 예방 또는 치료용 조성물
US20160130293A1 (en) * 2013-05-24 2016-05-12 Korea Research Institute Bioscience Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes
WO2020003363A1 (ja) * 2018-06-25 2020-01-02 学校法人近畿大学 ニコチン摂取の影響による血管の劣化を防止するための健康食品または医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6112624A (ja) * 1984-06-27 1986-01-21 Zenyaku Kogyo Kk 抗高血圧剤
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
EP0826369B1 (en) * 1989-07-21 2003-06-04 Suntory Limited Therapeutic use of dioxabicyclo (3.3.0)octane compounds
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH06112624A (ja) * 1992-09-28 1994-04-22 Matsushita Electric Ind Co Ltd 表面実装方法
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤

Also Published As

Publication number Publication date
ATE192648T1 (de) 2000-05-15
KR20070108292A (ko) 2007-11-09
PT729753E (pt) 2000-10-31
US5889046A (en) 1999-03-30
EP0729753B1 (en) 2000-05-10
DE69608155T2 (de) 2000-09-28
JPH08268887A (ja) 1996-10-15
AU4223696A (en) 1996-08-08
DK0729753T3 (da) 2000-08-07
EP0729753A1 (en) 1996-09-04
AU705308B2 (en) 1999-05-20
CA2168513A1 (en) 1996-08-02
KR960030937A (ko) 1996-09-17
KR100399671B1 (ko) 2003-12-31
DE69608155D1 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
ES2145379T3 (es) Uso de dioxabiciclo(3.3.0)octanos para el tratamiento y la prevencion de la apoplejia cerebral.
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
ES2193391T3 (es) Antagonistas muscarinicos.
ES2165505T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
GT199900146A (es) Derivados de 4,4-biarilpiperidina.
ES2148503T3 (es) Derivados de 3-aril-4-hidroxi-delta3-dihidrotiofenona.
MY140557A (en) Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
ES2106700T3 (es) Procedimiento para la preparacion de derivados de la 4a,5,9,10,11,12-hexahidro-6h-benzofuro(3a,3,2-ef)(2)benzacepinas.
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
DK0644878T3 (da) 2,5-Dioxo-2,5-dihydro-1H-benz[b[azepiner som NDMA-receptor-antagonister
ATE325610T1 (de) Xanthinderivative zur behandlung von hirnischämie
ES2182114T3 (es) Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
GT200100220A (es) Nuevos heteroaromatos.
PT768083E (pt) Sertralina para o tratamento de doentes pos-enfarte miocardico
GR1003725B (el) Νεες ενωσεις με συνδυασμενη αντιοξειδωτικη και αντιαρρυθμικη δραση
DE69905489T2 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
DK1001956T3 (da) 2,3-Benzodiazepinderivater
ES2170402T3 (es) Derivados de benzo(g)quinolina.
ES2186923T3 (es) Derivados del 2-carboniltiazol y su utilizacion.
ATE204847T1 (de) Tetracyclische aromatische retinoide verbindungen,ihre herstellung und verwendung
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
ES2158089T3 (es) Uso de derivados de fosforo de alcaloides para el tratamiento de endocrinopatias.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 729753

Country of ref document: ES